Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, April 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Pandemic Fraud

A federal class action claims that SCWorx and its CEO Marc S. Schessel falsely claimed that they had sold 2 million “Covid-19 rapid testing kits, ‘with provision for additional weekly orders of 2 million units for 23 weeks, valued at $35M per week,’” goosing its stock price, after which the SEC halted trading in it.

MANHATTAN — A federal class action claims that SCWorx and its CEO falsely claimed that they had sold 2 million “Covid-19 rapid testing kits, ‘with provision for additional weekly orders of 2 million units for 23 weeks, valued at $35M per week,’” goosing its stock price, after which the SEC halted trading in it.

Categories / Health, Securities

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...